User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

All Publications

Displaying 3 results.
    • Journal article
    Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study.
    Maher, Toby M Stowasser, Susanne Nishioka, Yasuhiko White, Eric S Cottin, Vincent Noth, Imre Selman, Moisés Rohr, Klaus B Michael, Andreas Ittrich, Carina Diefenbach, Claudia Jenkins, R Gisli INMARK trial investigators Dahlqvist, Caroline[UCL] (2019) The Lancet. Respiratory medicine — Vol. 7, no. 9, p. 771-779 (2019)
    • Journal article
    Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
    Distler, Oliver Highland, Kristin B Gahlemann, Martina Azuma, Arata Fischer, Aryeh Mayes, Maureen D Raghu, Ganesh Sauter, Wiebke Girard, Mannaig Alves, Margarida Clerisme-Beaty, Emmanuelle Stowasser, Susanne Tetzlaff, Kay Kuwana, Masataka Maher, Toby M SENSCIS Trial Investigators Houssiau, Frédéric[UCL] (2019) The New England journal of medicine — Vol. 380, no.26, p. 2518-2528 (2019)
    • Journal article
    Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
    Maher, Toby M Ford, Paul Brown, Kevin K Costabel, Ulrich Cottin, Vincent Danoff, Sonye K Groenveld, Irene Helmer, Eric Jenkins, R Gisli Milner, Julie Molenberghs, Geert Penninckx, Bjorn Randall, Matthew J Van Den Blink, Bernt Fieuw, Ann Vandenrijn, Charlotte Rocak, Sanda Seghers, Ineke Shao, Lixin Taneja, Amit Jentsch, Garrit Watkins, Timothy R Wuyts, Wim A Kreuter, Michael Verbruggen, Nadia Prasad, Niyati Wijsenbeek, Marlies S ISABELA 1 and 2 Investigators Froidure, Antoine[UCL] (2023) JAMA — Vol. 329, no.18, p. 1567-1578 (2023)